Press Release Distribution & PR Platform - ACCESS Newswire
5 hours ago • Google News
Biodexa Pharmaceticals (BDRX)
US$ 4.07-2.4%
Price Chart
Key Statistics
Market Cap
$ 3.64M
P/E Ratio
0.00
Revenue (TTM)
$ 83K
Volume
7.37K
52W High
$ 74.00
52W Low
$ 1.14
Dividend Yield
0.00%
Beta
1.71
Technicals
50-Day MA
2.4993
200-Day MA
7.4021
52 Week High
73.9975
52 Week Low
1.14
About BDRX
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lea.
Employees
13
Headquarters
Cardiff, United Kingdom
CEO
Mr. Stephen Anthony Stamp
Latest News
What Makes Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) a New Buy Stock - Yahoo Finance
12 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg